Julphar Gulf Pharmaceutical Industry
Julphar Gulf Pharmaceutical Industries is the largest generic pharmaceutical manufacturer in Middle East and North Africa and distributes medicines to over 40 countries. Established in 1980 in the United Arab Emirates under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi, Julphar’s first stand-alone facility produced only five products. Over three decades later, we operate fifteen internationally certified manufacturing facilities globally, produce over a million boxes of medicines daily and hold 4,074 product registration certificates.
Thirteen of our facilities are based in the UAE and cover production areas including tablets, syrups and suspensions. Julphar has also launched manufacturing facilities in Ethiopia and in Bangladesh as part of its ongoing international expansion strategy, and its Saudi Arabia facility is expected to begin its operations in 2017.
In 2012 Julphar launched a 150 million-dollar Active Pharmaceutical Ingredient (API) manufacturing facility – Julphar Diabetes – entirely dedicated to producing raw material needed for insulin formulation. Julphar Diabetes has the capacity to produce 1,500 kg of recombinant human insulin and insulin analogues crystals (rDNA), equivalent to 40 million vials of insulin per year. This positions Julphar among the largest manufacturers of insulin in the world, and the only one of its kind in the Middle East.
Julphar maintains a diverse product portfolio which targets major therapeutic segments. It includes the following categories: Wound, Anemia and Women Care, Adult Primary Care, Pediatric Primary Care, Gastro Care and Pain Management, Cardiopulmonary Care, and Consumer Care.
As part of its on-going responsibility, Julphar partners with local and global companies to make a positive impact across all healthcare sectors by funding scholarships for educational facilities and by providing sponsorship of various health campaigns across MENA.
Julphar employs approximately 3,000 people around the world and registered sales revenue of AED 1.47 billion in the year ending 2015, demonstrating a significant growth based on last year’s results. Emerging markets remain a key priority for sustainable growth, as Julphar’s Middle Eastern roots allow us to reach difficult markets in a timely manner.
With 83 registered products sold in over 40 countries, Julphar is a stellar example of one of the UAE’s local businesses making an impact on the global stage.
Julphar is Current Good Manufacturing Practice (cGMP) compliant and has gained ISO9001 and ISO 14001 accreditations, as well as the EU Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certifications. We work closely with regulatory bodies, such as the UAE Ministry of Health (MOH) and the US Food and Drug Administration (FDA) to ensure all our practices are aligned with the international requirements.
Julphar in essence is Sustaining Health across the globe.
NEW DELHI—India’s government on Monday eased foreign-direct investment restrictions in several sectors to increase inflows, a move that also could pave the way for Apple Inc. to open its own stores in one of its main growth markets.
A surge in cross-border mergers and acquisitions boosted global foreign direct investment flows around the world last year to $1.76 trillion, the most since the 2008-2009 financial crisis, the United Nations said in a study.
The ‘Foreign Direct Investment in Latin America and the Caribbean’ 2015 report published by Economic Commission for Latin America and the Caribbean (ECLAC) showed that Mexico recorded inflows of US$ 22.795 billion in 2014. Brazil continues to be the largest recipient of FDI in the region, though inflows US$ 62.495 billion, while Chile remains the … Continue reading Organisers of Annual Investment Meeting 2016 call for building investment bridges between Middle East and South America
The role of foreign direct investment into the continent remains significant: on average the government budgets of African countries currently depend on corporates domiciled in other countries for 14% of their funding.
Africa is now positioning itself as a major business opportunity for investors, according to ICAEW’s latest Economic Insight report.
China’s outbound direct investment (ODI )is expected to surpass $1 trillion for the first time in 2015, as slowing economic growth and rising internationalisation of Chinese business see more local companies investing overseas.
When the PM travels to the US this week to woo businesses there, one of the key facts that the government will be tomtoming about is the surge in foreign direct investment since Narendra Modi took over and how his personal touch has helped.
Foreign direct investment (FDI) in Turkey reached $3.39 billion in July, according to a report from the Ministry of Economy on Sept. 30.
The total volume of foreign investments in the UAE, at present a regional base for over 500 international companies, exceeded $100 billion in the past 10 years, Minister of Economy Sultan bin Saeed Al Mansouri said on Wednesday.
NEW DELHI: India has emerged on top of the foreign direct investment league table, overtaking China and the United States, according to the FT data service.